Free Trial
NASDAQ:INNV

InnovAge (INNV) Stock Price, News & Analysis

$4.53
+0.22 (+5.10%)
(As of 05/21/2024 ET)
Today's Range
$4.31
$4.69
50-Day Range
$3.55
$4.99
52-Week Range
$3.52
$8.05
Volume
32,615 shs
Average Volume
26,206 shs
Market Capitalization
$616.03 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$6.50

InnovAge MarketRank™ Stock Analysis

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
43.5% Upside
$6.50 Price Target
Short Interest
Bearish
1.73% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.43mentions of InnovAge in the last 14 days
Based on 5 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.49 out of 5 stars

Medical Sector

874th out of 920 stocks

Health Services Industry

8th out of 9 stocks

INNV stock logo

About InnovAge Stock (NASDAQ:INNV)

InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in their homes and communities. The company manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach. It also offers in-home care services consisting of skilled, unskilled, and personal care; in-center services, such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to the PACE center and third-party medical appointments; and care management. The company serves participants in the United States; and operates PACE centers in Colorado, California, New Mexico, Pennsylvania, and Virginia. The company was formerly known as TCO Group Holdings, Inc. and changed its name to InnovAge Holding Corp. in January 2021. InnovAge Holding Corp. was founded in 2007 and is headquartered in Denver, Colorado.

INNV Stock Price History

INNV Stock News Headlines

InnovAge Holding Corp (INNV)
INNV InnovAge Holding Corp.
InnovAge Holding: A Cautious Hold Amidst Mixed Financial Signals
Recap: InnovAge Holding Q2 Earnings
InnovAge Holding Corp INNV
InnovAge Revenue Ticks Up, But Challenges Remain
See More Headlines
Receive INNV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for InnovAge and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/05/2024
Today
5/21/2024
Fiscal Year End
6/30/2024
Next Earnings (Estimated)
9/10/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Health services
Sub-Industry
N/A
Current Symbol
NASDAQ:INNV
Fax
N/A
Employees
2,100
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$6.50
High Stock Price Target
$7.00
Low Stock Price Target
$6.00
Potential Upside/Downside
+43.5%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
2 Analysts

Profitability

Net Income
$-40,670,000.00
Pretax Margin
-4.37%

Debt

Sales & Book Value

Annual Sales
$688.09 million
Book Value
$2.23 per share

Miscellaneous

Free Float
135,430,000
Market Cap
$616.03 million
Optionable
Optionable
Beta
0.24
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Key Executives

  • Mr. Patrick Blair (Age 53)
    President & CEO
    Comp: $1.51M
  • Ms. Nicole D'Amato (Age 45)
    Chief Legal Officer & Corporate Secretary
    Comp: $678.76k
  • Dr. Richard A. Feifer FACP (Age 57)
    M.D., M.P.H., Chief Medical Officer
    Comp: $588.97k
  • Mr. Edward Moore Kennedy Jr. (Age 63)
    J.D., Independent Director
    Comp: $100k
  • Hon. Marilyn Barbour Tavenner M.H.A. (Age 62)
    R.N., Independent Director
    Comp: $120k
  • Mr. Benjamin Crowninshield Adams (Age 60)
    Chief Financial Officer
  • Ms. Christine Bent (Age 53)
    Chief Operations Officer
  • Ms. Cara Babachicos
    Chief Information Officer
  • Mr. Ryan Kubota
    Director of Investor Relations
  • Ms. Olivia Patton
    Chief Compliance Officer

INNV Stock Analysis - Frequently Asked Questions

Should I buy or sell InnovAge stock right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for InnovAge in the last twelve months. There are currently 2 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" INNV shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in INNV, but not buy additional shares or sell existing shares.
View INNV analyst ratings
or view top-rated stocks.

What is InnovAge's stock price target for 2024?

2 brokerages have issued 12-month target prices for InnovAge's shares. Their INNV share price targets range from $6.00 to $7.00. On average, they predict the company's stock price to reach $6.50 in the next twelve months. This suggests a possible upside of 43.5% from the stock's current price.
View analysts price targets for INNV
or view top-rated stocks among Wall Street analysts.

How have INNV shares performed in 2024?

InnovAge's stock was trading at $6.00 at the beginning of 2024. Since then, INNV shares have decreased by 24.5% and is now trading at $4.53.
View the best growth stocks for 2024 here
.

When is InnovAge's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, September 10th 2024.
View our INNV earnings forecast
.

How were InnovAge's earnings last quarter?

InnovAge Holding Corp. (NASDAQ:INNV) posted its quarterly earnings data on Monday, February, 5th. The company reported ($0.03) earnings per share for the quarter, hitting analysts' consensus estimates of ($0.03). The firm had revenue of $188.90 million for the quarter, compared to analyst estimates of $181.51 million. InnovAge had a negative trailing twelve-month return on equity of 10.51% and a negative net margin of 4.16%. During the same period in the prior year, the company posted ($0.07) earnings per share.

What guidance has InnovAge issued on next quarter's earnings?

InnovAge updated its FY 2024 earnings guidance on Wednesday, May, 8th. The company provided EPS guidance of for the period. The company issued revenue guidance of $725.0 million-$775.0 million, compared to the consensus revenue estimate of $755.3 million.

When did InnovAge IPO?

InnovAge (INNV) raised $301 million in an IPO on Thursday, March 4th 2021. The company issued 16,700,000 shares at a price of $17.00-$19.00 per share. J.P. Morgan, Barclays, Goldman Sachs and Citigroup served as the underwriters for the IPO and Baird, William Blair, Piper Sandler, Capital One Securities, Loop Capital Markets, Siebert Williams Shank and Roberts & Ryan were co-managers.

Who are InnovAge's major shareholders?

InnovAge's stock is owned by a number of retail and institutional investors. Top institutional investors include Vanguard Group Inc. (1.36%) and Kent Lake Capital LLC (1.29%).

How do I buy shares of InnovAge?

Shares of INNV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:INNV) was last updated on 5/22/2024 by MarketBeat.com Staff

From Our Partners